APO Research
Talk to an analyst

APO RESEARCH · REPORT

Herpes Zoste Drug

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Herpes Zoste Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

26 December 2025192 pages

Choose your research edition.

Industry ResearchHerpes Zoste Drug Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Herpes Zoste Drug Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Herpes Zoste Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Herpes Zoste Drug Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Herpes Zoste Drug Market Analysis and Forecast 2026-2032212 pages · $4,950 USD

Market perspective

The global Herpes Zoste Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Herpes Zoste Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Herpes Zoste Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Herpes Zoste Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Herpes Zoste Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Herpes Zoste Drug include Merck & Co., Inc., Beijing Minhai Biotechnology Co., Ltd, Astellas Pharma Inc., TSRL, Inc., ReceptoPharm, Inc., NAL Pharmaceuticals Ltd., GlaxoSmithKline Plc, GeneOne Life Science, Inc. and Foamix Pharmaceuticals Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

On the production side, the report examines Herpes Zoste Drug output, growth rates, and market shares by manufacturer and by region (at regional and country level) for 2021-2026, with forecasts through 2032.

On the consumption side, the report analyzes sales of Herpes Zoste Drug by region (regional and country level), company, type, and application for 2021-2026 and provides forecasts through 2032.

The report provides an overview of the global Herpes Zoste Drug market in terms of capacity, output, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Herpes Zoste Drug and consumption patterns in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Herpes Zoste Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by type and application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Herpes Zoste Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Herpes Zoste Drug Segment by Company

Merck & Co., Inc.

Beijing Minhai Biotechnology Co., Ltd

Astellas Pharma Inc.

TSRL, Inc.

ReceptoPharm, Inc.

NAL Pharmaceuticals Ltd.

GlaxoSmithKline Plc

GeneOne Life Science, Inc.

Foamix Pharmaceuticals Ltd.

Epiphany Biosciences, Inc.

ContraVir Pharmaceuticals, Inc.

Herpes Zoste Drug Segment by Type

FV-100

GLS-5100

GSK-1437173A

NAL-3221

Amenamevir

Acyclovir

Others

Herpes Zoste Drug Segment by Application

Clinic

Hospital

Others

Herpes Zoste Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Herpes Zoste Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Herpes Zoste Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Herpes Zoste Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Herpes Zoste Drug market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Herpes Zoste Drug industry.

Chapter 3: Detailed analysis of Herpes Zoste Drug market competition landscape. Including Herpes Zoste Drug manufacturers' output value, output and average price from 2021 to 2026, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 7: Production/Production Value of Herpes Zoste Drug by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 8: Consumption of Herpes Zoste Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Herpes Zoste Drug Industry Trends Table 2. Herpes Zoste Drug Industry Drivers Table 3. Herpes Zoste Drug Industry Opportunities and Challenges Table 4. Herpes Zoste Drug Industry Restraints Table 5. Global Herpes Zoste Drug Production Value by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Herpes Zoste Drug Production Value Share by Manufacturers (2021-2026) Table 7. Global Herpes Zoste Drug Production by Manufacturers (W Units) & (2021-2026) Table 8. Global Herpes Zoste Drug Production Market Share by Manufacturers Table 9. Global Herpes Zoste Drug Average Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Herpes Zoste Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Herpes Zoste Drug Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Herpes Zoste Drug Manufacturers, Product Type & Application Table 13. Global Herpes Zoste Drug Manufacturers Established Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Herpes Zoste Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value of 2025) Table 16. Major Manufacturers of FV-100 Table 17. Major Manufacturers of GLS-5100 Table 18. Major Manufacturers of GSK-1437173A Table 19. Major Manufacturers of NAL-3221 Table 20. Major Manufacturers of Amenamevir Table 21. Major Manufacturers of Acyclovir Table 22. Major Manufacturers of Others Table 23. Global Herpes Zoste Drug Production by Type 2021 VS 2025 VS 2032 (W Units) Table 24. Global Herpes Zoste Drug Production by Type (2021-2026) & (W Units) Table 25. Global Herpes Zoste Drug Production by Type (2027-2032) & (W Units) Table 26. Global Herpes Zoste Drug Production Market Share by Type (2021-2026) Table 27. Global Herpes Zoste Drug Production Market Share by Type (2027-2032) Table 28. Global Herpes Zoste Drug Production Value by Type 2021 VS 2025 VS 2032 (W Units) Table 29. Global Herpes Zoste Drug Production Value by Type (2021-2026) & (W Units) Table 30. Global Herpes Zoste Drug Production Value by Type (2027-2032) & (W Units) Table 31. Global Herpes Zoste Drug Production Value Market Share by Type (2021-2026) Table 32. Global Herpes Zoste Drug Production Value Market Share by Type (2027-2032) Table 33. Major Manufacturers of Clinic Table 34. Major Manufacturers of Hospital Table 35. Major Manufacturers of Others Table 36. Global Herpes Zoste Drug Production by Application 2021 VS 2025 VS 2032 (W Units) Table 37. Global Herpes Zoste Drug Production by Application (2021-2026) & (W Units) Table 38. Global Herpes Zoste Drug Production by Application (2027-2032) & (W Units) Table 39. Global Herpes Zoste Drug Production Market Share by Application (2021-2026) Table 40. Global Herpes Zoste Drug Production Market Share by Application (2027-2032) Table 41. Global Herpes Zoste Drug Production Value by Application 2021 VS 2025 VS 2032 (W Units) Table 42. Global Herpes Zoste Drug Production Value by Application (2021-2026) & (W Units) Table 43. Global Herpes Zoste Drug Production Value by Application (2027-2032) & (W Units) Table 44. Global Herpes Zoste Drug Production Value Market Share by Application (2021-2026) Table 45. Global Herpes Zoste Drug Production Value Market Share by Application (2027-2032) Table 46. Merck & Co., Inc. Company Information Table 47. Merck & Co., Inc. Business Overview Table 48. Merck & Co., Inc. Herpes Zoste Drug Production (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 49. Merck & Co., Inc. Herpes Zoste Drug Product Portfolio Table 50. Merck & Co., Inc. Recent Development Table 51. Beijing Minhai Biotechnology Co., Ltd Company Information Table 52. Beijing Minhai Biotechnology Co., Ltd Business Overview Table 53. Beijing Minhai Biotechnology Co., Ltd Herpes Zoste Drug Production (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 54. Beijing Minhai Biotechnology Co., Ltd Herpes Zoste Drug Product Portfolio Table 55. Beijing Minhai Biotechnology Co., Ltd Recent Development Table 56. Astellas Pharma Inc. Company Information Table 57. Astellas Pharma Inc. Business Overview Table 58. Astellas Pharma Inc. Herpes Zoste Drug Production (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 59. Astellas Pharma Inc. Herpes Zoste Drug Product Portfolio Table 60. Astellas Pharma Inc. Recent Development Table 61. TSRL, Inc. Company Information Table 62. TSRL, Inc. Business Overview Table 63. TSRL, Inc. Herpes Zoste Drug Production (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 64. TSRL, Inc. Herpes Zoste Drug Product Portfolio Table 65. TSRL, Inc. Recent Development Table 66. ReceptoPharm, Inc. Company Information Table 67. ReceptoPharm, Inc. Business Overview Table 68. ReceptoPharm, Inc. Herpes Zoste Drug Production (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. ReceptoPharm, Inc. Herpes Zoste Drug Product Portfolio Table 70. ReceptoPharm, Inc. Recent Development Table 71. NAL Pharmaceuticals Ltd. Company Information Table 72. NAL Pharmaceuticals Ltd. Business Overview Table 73. NAL Pharmaceuticals Ltd. Herpes Zoste Drug Production (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. NAL Pharmaceuticals Ltd. Herpes Zoste Drug Product Portfolio Table 75. NAL Pharmaceuticals Ltd. Recent Development Table 76. GlaxoSmithKline Plc Company Information Table 77. GlaxoSmithKline Plc Business Overview Table 78. GlaxoSmithKline Plc Herpes Zoste Drug Production (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. GlaxoSmithKline Plc Herpes Zoste Drug Product Portfolio Table 80. GlaxoSmithKline Plc Recent Development Table 81. GeneOne Life Science, Inc. Company Information Table 82. GeneOne Life Science, Inc. Business Overview Table 83. GeneOne Life Science, Inc. Herpes Zoste Drug Production (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. GeneOne Life Science, Inc. Herpes Zoste Drug Product Portfolio Table 85. GeneOne Life Science, Inc. Recent Development Table 86. Foamix Pharmaceuticals Ltd. Company Information Table 87. Foamix Pharmaceuticals Ltd. Business Overview Table 88. Foamix Pharmaceuticals Ltd. Herpes Zoste Drug Production (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Foamix Pharmaceuticals Ltd. Herpes Zoste Drug Product Portfolio Table 90. Foamix Pharmaceuticals Ltd. Recent Development Table 91. Epiphany Biosciences, Inc. Company Information Table 92. Epiphany Biosciences, Inc. Business Overview Table 93. Epiphany Biosciences, Inc. Herpes Zoste Drug Production (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Epiphany Biosciences, Inc. Herpes Zoste Drug Product Portfolio Table 95. Epiphany Biosciences, Inc. Recent Development Table 96. ContraVir Pharmaceuticals, Inc. Company Information Table 97. ContraVir Pharmaceuticals, Inc. Business Overview Table 98. ContraVir Pharmaceuticals, Inc. Herpes Zoste Drug Production (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. ContraVir Pharmaceuticals, Inc. Herpes Zoste Drug Product Portfolio Table 100. ContraVir Pharmaceuticals, Inc. Recent Development Table 101. Global Herpes Zoste Drug Production by Region: 2021 VS 2025 VS 2032 (W Units) Table 102. Global Herpes Zoste Drug Production by Region (2021-2026) & (W Units) Table 103. Global Herpes Zoste Drug Production Market Share by Region (2021-2026) Table 104. Global Herpes Zoste Drug Production Forecast by Region (2027-2032) & (W Units) Table 105. Global Herpes Zoste Drug Production Market Share Forecast by Region (2027-2032) Table 106. Global Herpes Zoste Drug Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 107. Global Herpes Zoste Drug Production Value by Region (2021-2026) & (US$ Million) Table 108. Global Herpes Zoste Drug Production Value Share by Region (2021-2026) Table 109. Global Herpes Zoste Drug Production Value by Region (2027-2032) & (US$ Million) Table 110. Global Herpes Zoste Drug Production Value Share by Region: (2027-2032) & (US$ Million) Table 111. Global Herpes Zoste Drug Market Average Price (US$/Unit) by Region (2021-2026) Table 112. Global Herpes Zoste Drug Market Average Price (US$/Unit) by Region (2027-2032) Table 113. Global Herpes Zoste Drug Consumption by Region: 2021 VS 2025 VS 2032 (W Units) Table 114. Global Herpes Zoste Drug Consumption by Region (2021-2026) & (W Units) Table 115. Global Herpes Zoste Drug Consumption Market Share by Region (2021-2026) Table 116. Global Herpes Zoste Drug Consumption Forecasted by Region (2027-2032) & (W Units) Table 117. Global Herpes Zoste Drug Consumption Forecasted Market Share by Region (2027-2032) Table 118. North America Herpes Zoste Drug Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 119. North America Herpes Zoste Drug Consumption by Country (2021-2026) & (W Units) Table 120. North America Herpes Zoste Drug Consumption by Country (2027-2032) & (W Units) Table 121. Europe Herpes Zoste Drug Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 122. Europe Herpes Zoste Drug Consumption by Country (2021-2026) & (W Units) Table 123. Europe Herpes Zoste Drug Consumption by Country (2027-2032) & (W Units) Table 124. Asia Pacific Herpes Zoste Drug Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 125. Asia Pacific Herpes Zoste Drug Consumption by Country (2021-2026) & (W Units) Table 126. Asia Pacific Herpes Zoste Drug Consumption by Country (2027-2032) & (W Units) Table 127. South America Herpes Zoste Drug Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 128. South America Herpes Zoste Drug Consumption by Country (2021-2026) & (W Units) Table 129. South America Herpes Zoste Drug Consumption by Country (2027-2032) & (W Units) Table 130. Middle East & Africa Herpes Zoste Drug Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 131. Middle East & Africa Herpes Zoste Drug Consumption by Country (2021-2026) & (W Units) Table 132. Middle East & Africa Herpes Zoste Drug Consumption by Country (2027-2032) & (W Units) Table 133. Key Raw Materials Table 134. Raw Materials Key Suppliers Table 135. Herpes Zoste Drug Distributors List Table 136. Herpes Zoste Drug Customers List Table 137. Research Programs/Design for This Report Table 138. Authors List of This Report Table 139. Secondary Sources Table 140. Primary Sources List of Figures Figure 1. Herpes Zoste Drug Product Image Figure 2. Global Herpes Zoste Drug Production Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Herpes Zoste Drug Production Value (2021-2032) & (US$ Million) Figure 4. Global Herpes Zoste Drug Production Capacity (2021-2032) & (W Units) Figure 5. Global Herpes Zoste Drug Production (2021-2032) & (W Units) Figure 6. Global Herpes Zoste Drug Average Price (US$/Unit) & (2021-2032) Figure 7. Global Top 5 and 10 Herpes Zoste Drug Players Market Share by Production Value in 2025 Figure 8. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. FV-100 Image Figure 10. GLS-5100 Image Figure 11. GSK-1437173A Image Figure 12. NAL-3221 Image Figure 13. Amenamevir Image Figure 14. Acyclovir Image Figure 15. Others Image Figure 16. Global Herpes Zoste Drug Production by Type (2021 VS 2025 VS 2032) & (W Units) Figure 17. Global Herpes Zoste Drug Production Market Share 2021 VS 2025 VS 2032 Figure 18. Global Herpes Zoste Drug Production Market Share by Type (2021-2032) Figure 19. Global Herpes Zoste Drug Production Value by Type (2021 VS 2025 VS 2032) & (W Units) Figure 20. Global Herpes Zoste Drug Production Value Share 2021 VS 2025 VS 2032 Figure 21. Global Herpes Zoste Drug Production Value Share by Type (2021-2032) Figure 22. Clinic Image Figure 23. Hospital Image Figure 24. Others Image Figure 25. Global Herpes Zoste Drug Production by Application (2021 VS 2025 VS 2032) & (W Units) Figure 26. Global Herpes Zoste Drug Production Market Share 2021 VS 2025 VS 2032 Figure 27. Global Herpes Zoste Drug Production Market Share by Application (2021-2032) Figure 28. Global Herpes Zoste Drug Production Value by Application (2021 VS 2025 VS 2032) & (W Units) Figure 29. Global Herpes Zoste Drug Production Value Share 2021 VS 2025 VS 2032 Figure 30. Global Herpes Zoste Drug Production Value Share by Application (2021-2032) Figure 31. Global Herpes Zoste Drug Production by Region: 2021 VS 2025 VS 2032 (W Units) Figure 32. Global Herpes Zoste Drug Production Market Share by Region: 2021 VS 2025 VS 2032 Figure 33. Global Herpes Zoste Drug Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 34. Global Herpes Zoste Drug Production Value Share by Region: 2021 VS 2025 VS 2032 Figure 35. North America Herpes Zoste Drug Production Value (2021-2032) & (US$ Million) Figure 36. Europe Herpes Zoste Drug Production Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Herpes Zoste Drug Production Value (2021-2032) & (US$ Million) Figure 38. South America Herpes Zoste Drug Production Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Herpes Zoste Drug Production Value (2021-2032) & (US$ Million) Figure 40. North America Herpes Zoste Drug Consumption and Growth Rate (2021-2032) & (W Units) Figure 41. North America Herpes Zoste Drug Consumption Market Share by Country (2021-2032) Figure 42. U.S. Herpes Zoste Drug Consumption and Growth Rate (2021-2032) & (W Units) Figure 43. Canada Herpes Zoste Drug Consumption and Growth Rate (2021-2032) & (W Units) Figure 44. Mexico Herpes Zoste Drug Consumption and Growth Rate (2021-2032) & (W Units) Figure 45. Europe Herpes Zoste Drug Consumption and Growth Rate (2021-2032) & (W Units) Figure 46. Europe Herpes Zoste Drug Consumption Market Share by Country (2021-2032) Figure 47. Germany Herpes Zoste Drug Consumption and Growth Rate (2021-2032) & (W Units) Figure 48. France Herpes Zoste Drug Consumption and Growth Rate (2021-2032) & (W Units) Figure 49. U.K. Herpes Zoste Drug Consumption and Growth Rate (2021-2032) & (W Units) Figure 50. Italy Herpes Zoste Drug Consumption and Growth Rate (2021-2032) & (W Units) Figure 51. Netherlands Herpes Zoste Drug Consumption and Growth Rate (2021-2032) & (W Units) Figure 52. Asia Pacific Herpes Zoste Drug Consumption and Growth Rate (2021-2032) & (W Units) Figure 53. Asia Pacific Herpes Zoste Drug Consumption Market Share by Country (2021-2032) Figure 54. China Herpes Zoste Drug Consumption and Growth Rate (2021-2032) & (W Units) Figure 55. Japan Herpes Zoste Drug Consumption and Growth Rate (2021-2032) & (W Units) Figure 56. South Korea Herpes Zoste Drug Consumption and Growth Rate (2021-2032) & (W Units) Figure 57. Southeast Asia Herpes Zoste Drug Consumption and Growth Rate (2021-2032) & (W Units) Figure 58. India Herpes Zoste Drug Consumption and Growth Rate (2021-2032) & (W Units) Figure 59. Australia Herpes Zoste Drug Consumption and Growth Rate (2021-2032) & (W Units) Figure 60. South America Herpes Zoste Drug Consumption and Growth Rate (2021-2032) & (W Units) Figure 61. South America Herpes Zoste Drug Consumption Market Share by Country (2021-2032) Figure 62. Brazil Herpes Zoste Drug Consumption and Growth Rate (2021-2032) & (W Units) Figure 63. Argentina Herpes Zoste Drug Consumption and Growth Rate (2021-2032) & (W Units) Figure 64. Chile Herpes Zoste Drug Consumption and Growth Rate (2021-2032) & (W Units) Figure 65. Colombia Herpes Zoste Drug Consumption and Growth Rate (2021-2032) & (W Units) Figure 66. Middle East & Africa Herpes Zoste Drug Consumption and Growth Rate (2021-2032) & (W Units) Figure 67. Middle East & Africa Herpes Zoste Drug Consumption Market Share by Country (2021-2032) Figure 68. Egypt Herpes Zoste Drug Consumption and Growth Rate (2021-2032) & (W Units) Figure 69. South Africa Herpes Zoste Drug Consumption and Growth Rate (2021-2032) & (W Units) Figure 70. Israel Herpes Zoste Drug Consumption and Growth Rate (2021-2032) & (W Units) Figure 71. Türkiye Herpes Zoste Drug Consumption and Growth Rate (2021-2032) & (W Units) Figure 72. GCC Countries Herpes Zoste Drug Consumption and Growth Rate (2021-2032) & (W Units) Figure 73. Herpes Zoste Drug Value Chain Figure 74. Manufacturing Cost Structure Figure 75. Herpes Zoste Drug Production Mode & Process Figure 76. Direct Comparison with Distribution Share Figure 77. Distributors Profiles Figure 78. Years Considered Figure 79. Research Process Figure 80. Key Executives Interviewed

Scope & coverage.

Types
  • FV-100
  • GLS-5100
  • GSK-1437173A
  • NAL-3221
  • Amenamevir
  • Acyclovir
  • Others
Applications
  • Clinic
  • Hospital
  • Others
Companies covered
  • Merck & Co., Inc.
  • Beijing Minhai Biotechnology Co., Ltd
  • Astellas Pharma Inc.
  • TSRL, Inc.
  • ReceptoPharm, Inc.
  • NAL Pharmaceuticals Ltd.
  • GlaxoSmithKline Plc
  • GeneOne Life Science, Inc.
  • Foamix Pharmaceuticals Ltd.
  • Epiphany Biosciences, Inc.
  • ContraVir Pharmaceuticals, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Herpes Zoste Drug Production Value Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Herpes Zoste Drug Production Capacity Estimates and Forecasts (2021-2032)
  5. 1.2.3 Global Herpes Zoste Drug Production Estimates and Forecasts (2021-2032)
  6. 1.2.4 Global Herpes Zoste Drug Market Average Price (2021-2032)
  7. 1.3 Assumptions and Limitations
  8. 1.4 Study Goals and Objectives
2 Global Herpes Zoste Drug Market Dynamics
  1. 2.1 Herpes Zoste Drug Industry Trends
  2. 2.2 Herpes Zoste Drug Industry Drivers
  3. 2.3 Herpes Zoste Drug Industry Opportunities and Challenges
  4. 2.4 Herpes Zoste Drug Industry Restraints
3 Herpes Zoste Drug Market by Manufacturers
  1. 3.1 Global Herpes Zoste Drug Production Value by Manufacturers (2021-2026)
  2. 3.2 Global Herpes Zoste Drug Production by Manufacturers (2021-2026)
  3. 3.3 Global Herpes Zoste Drug Average Price by Manufacturers (2021-2026)
  4. 3.4 Global Herpes Zoste Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Herpes Zoste Drug Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Herpes Zoste Drug Manufacturers, Product Type & Application
  7. 3.7 Global Herpes Zoste Drug Manufacturers Established Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Herpes Zoste Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Herpes Zoste Drug Players Market Share by Production Value in 2025
  11. 3.8.3 2025 Herpes Zoste Drug Tier 1, Tier 2, and Tier 3
4 Herpes Zoste Drug Market by Type
  1. 4.1 Herpes Zoste Drug Type Introduction
  2. 4.1.1 FV-100
  3. 4.1.2 GLS-5100
  4. 4.1.3 GSK-1437173A
  5. 4.1.4 NAL-3221
  6. 4.1.5 Amenamevir
  7. 4.1.6 Acyclovir
  8. 4.1.7 Others
  9. 4.2 Global Herpes Zoste Drug Production by Type
  10. 4.2.1 Global Herpes Zoste Drug Production by Type (2021 VS 2025 VS 2032)
  11. 4.2.2 Global Herpes Zoste Drug Production by Type (2021-2032)
  12. 4.2.3 Global Herpes Zoste Drug Production Market Share by Type (2021-2032)
  13. 4.3 Global Herpes Zoste Drug Production Value by Type
  14. 4.3.1 Global Herpes Zoste Drug Production Value by Type (2021 VS 2025 VS 2032)
  15. 4.3.2 Global Herpes Zoste Drug Production Value by Type (2021-2032)
  16. 4.3.3 Global Herpes Zoste Drug Production Value Market Share by Type (2021-2032)
5 Herpes Zoste Drug Market by Application
  1. 5.1 Herpes Zoste Drug Application Introduction
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Others
  5. 5.2 Global Herpes Zoste Drug Production by Application
  6. 5.2.1 Global Herpes Zoste Drug Production by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Herpes Zoste Drug Production by Application (2021-2032)
  8. 5.2.3 Global Herpes Zoste Drug Production Market Share by Application (2021-2032)
  9. 5.3 Global Herpes Zoste Drug Production Value by Application
  10. 5.3.1 Global Herpes Zoste Drug Production Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Herpes Zoste Drug Production Value by Application (2021-2032)
  12. 5.3.3 Global Herpes Zoste Drug Production Value Market Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Merck & Co., Inc.
  2. 6.1.1 Merck & Co., Inc. Company Information
  3. 6.1.2 Merck & Co., Inc. Business Overview
  4. 6.1.3 Merck & Co., Inc. Herpes Zoste Drug Production, Value and Gross Margin (2021-2026)
  5. 6.1.4 Merck & Co., Inc. Herpes Zoste Drug Product Portfolio
  6. 6.1.5 Merck & Co., Inc. Recent Developments
  7. 6.2 Beijing Minhai Biotechnology Co., Ltd
  8. 6.2.1 Beijing Minhai Biotechnology Co., Ltd Company Information
  9. 6.2.2 Beijing Minhai Biotechnology Co., Ltd Business Overview
  10. 6.2.3 Beijing Minhai Biotechnology Co., Ltd Herpes Zoste Drug Production, Value and Gross Margin (2021-2026)
  11. 6.2.4 Beijing Minhai Biotechnology Co., Ltd Herpes Zoste Drug Product Portfolio
  12. 6.2.5 Beijing Minhai Biotechnology Co., Ltd Recent Developments
  13. 6.3 Astellas Pharma Inc.
  14. 6.3.1 Astellas Pharma Inc. Company Information
  15. 6.3.2 Astellas Pharma Inc. Business Overview
  16. 6.3.3 Astellas Pharma Inc. Herpes Zoste Drug Production, Value and Gross Margin (2021-2026)
  17. 6.3.4 Astellas Pharma Inc. Herpes Zoste Drug Product Portfolio
  18. 6.3.5 Astellas Pharma Inc. Recent Developments
  19. 6.4 TSRL, Inc.
  20. 6.4.1 TSRL, Inc. Company Information
  21. 6.4.2 TSRL, Inc. Business Overview
  22. 6.4.3 TSRL, Inc. Herpes Zoste Drug Production, Value and Gross Margin (2021-2026)
  23. 6.4.4 TSRL, Inc. Herpes Zoste Drug Product Portfolio
  24. 6.4.5 TSRL, Inc. Recent Developments
  25. 6.5 ReceptoPharm, Inc.
  26. 6.5.1 ReceptoPharm, Inc. Company Information
  27. 6.5.2 ReceptoPharm, Inc. Business Overview
  28. 6.5.3 ReceptoPharm, Inc. Herpes Zoste Drug Production, Value and Gross Margin (2021-2026)
  29. 6.5.4 ReceptoPharm, Inc. Herpes Zoste Drug Product Portfolio
  30. 6.5.5 ReceptoPharm, Inc. Recent Developments
  31. 6.6 NAL Pharmaceuticals Ltd.
  32. 6.6.1 NAL Pharmaceuticals Ltd. Company Information
  33. 6.6.2 NAL Pharmaceuticals Ltd. Business Overview
  34. 6.6.3 NAL Pharmaceuticals Ltd. Herpes Zoste Drug Production, Value and Gross Margin (2021-2026)
  35. 6.6.4 NAL Pharmaceuticals Ltd. Herpes Zoste Drug Product Portfolio
  36. 6.6.5 NAL Pharmaceuticals Ltd. Recent Developments
  37. 6.7 GlaxoSmithKline Plc
  38. 6.7.1 GlaxoSmithKline Plc Company Information
  39. 6.7.2 GlaxoSmithKline Plc Business Overview
  40. 6.7.3 GlaxoSmithKline Plc Herpes Zoste Drug Production, Value and Gross Margin (2021-2026)
  41. 6.7.4 GlaxoSmithKline Plc Herpes Zoste Drug Product Portfolio
  42. 6.7.5 GlaxoSmithKline Plc Recent Developments
  43. 6.8 GeneOne Life Science, Inc.
  44. 6.8.1 GeneOne Life Science, Inc. Company Information
  45. 6.8.2 GeneOne Life Science, Inc. Business Overview
  46. 6.8.3 GeneOne Life Science, Inc. Herpes Zoste Drug Production, Value and Gross Margin (2021-2026)
  47. 6.8.4 GeneOne Life Science, Inc. Herpes Zoste Drug Product Portfolio
  48. 6.8.5 GeneOne Life Science, Inc. Recent Developments
  49. 6.9 Foamix Pharmaceuticals Ltd.
  50. 6.9.1 Foamix Pharmaceuticals Ltd. Company Information
  51. 6.9.2 Foamix Pharmaceuticals Ltd. Business Overview
  52. 6.9.3 Foamix Pharmaceuticals Ltd. Herpes Zoste Drug Production, Value and Gross Margin (2021-2026)
  53. 6.9.4 Foamix Pharmaceuticals Ltd. Herpes Zoste Drug Product Portfolio
  54. 6.9.5 Foamix Pharmaceuticals Ltd. Recent Developments
  55. 6.10 Epiphany Biosciences, Inc.
  56. 6.10.1 Epiphany Biosciences, Inc. Company Information
  57. 6.10.2 Epiphany Biosciences, Inc. Business Overview
  58. 6.10.3 Epiphany Biosciences, Inc. Herpes Zoste Drug Production, Value and Gross Margin (2021-2026)
  59. 6.10.4 Epiphany Biosciences, Inc. Herpes Zoste Drug Product Portfolio
  60. 6.10.5 Epiphany Biosciences, Inc. Recent Developments
  61. 6.11 ContraVir Pharmaceuticals, Inc.
  62. 6.11.1 ContraVir Pharmaceuticals, Inc. Company Information
  63. 6.11.2 ContraVir Pharmaceuticals, Inc. Business Overview
  64. 6.11.3 ContraVir Pharmaceuticals, Inc. Herpes Zoste Drug Production, Value and Gross Margin (2021-2026)
  65. 6.11.4 ContraVir Pharmaceuticals, Inc. Herpes Zoste Drug Product Portfolio
  66. 6.11.5 ContraVir Pharmaceuticals, Inc. Recent Developments
7 Global Herpes Zoste Drug Production by Region
  1. 7.1 Global Herpes Zoste Drug Production by Region: 2021 VS 2025 VS 2032
  2. 7.2 Global Herpes Zoste Drug Production by Region (2021-2032)
  3. 7.2.1 Global Herpes Zoste Drug Production by Region (2021-2026)
  4. 7.2.2 Global Herpes Zoste Drug Production Forecast by Region (2027-2032)
  5. 7.3 Global Herpes Zoste Drug Production by Region: 2021 VS 2025 VS 2032
  6. 7.4 Global Herpes Zoste Drug Production Value by Region (2021-2032)
  7. 7.4.1 Global Herpes Zoste Drug Production Value by Region (2021-2026)
  8. 7.4.2 Global Herpes Zoste Drug Production Value by Region (2027-2032)
  9. 7.5 Global Herpes Zoste Drug Market Price Analysis by Region (2021-2032)
  10. 7.6 Regional Production Value Trends (2021-2032)
  11. 7.6.1 North America Herpes Zoste Drug Production Value (2021-2032)
  12. 7.6.2 Europe Herpes Zoste Drug Production Value (2021-2032)
  13. 7.6.3 Asia-Pacific Herpes Zoste Drug Production Value (2021-2032)
  14. 7.6.4 South America Herpes Zoste Drug Production Value (2021-2032)
  15. 7.6.5 Middle East & Africa Herpes Zoste Drug Production Value (2021-2032)
8 Global Herpes Zoste Drug Consumption by Region
  1. 8.1 Global Herpes Zoste Drug Consumption by Region: 2021 VS 2025 VS 2032
  2. 8.2 Global Herpes Zoste Drug Consumption by Region (2021-2032)
  3. 8.2.1 Global Herpes Zoste Drug Consumption by Region (2021-2026)
  4. 8.2.2 Global Herpes Zoste Drug Consumption by Region (2027-2032)
  5. 8.3 North America
  6. 8.3.1 North America Herpes Zoste Drug Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 8.3.2 North America Herpes Zoste Drug Consumption by Country (2021-2032)
  8. 8.3.3 U.S.
  9. 8.3.4 Canada
  10. 8.3.5 Mexico
  11. 8.4 Europe
  12. 8.4.1 Europe Herpes Zoste Drug Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 8.4.2 Europe Herpes Zoste Drug Consumption by Country (2021-2032)
  14. 8.4.3 Germany
  15. 8.4.4 France
  16. 8.4.5 U.K.
  17. 8.4.6 Italy
  18. 8.4.7 Netherlands
  19. 8.5 Asia Pacific
  20. 8.5.1 Asia Pacific Herpes Zoste Drug Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 8.5.2 Asia Pacific Herpes Zoste Drug Consumption by Country (2021-2032)
  22. 8.5.3 China
  23. 8.5.4 Japan
  24. 8.5.5 South Korea
  25. 8.5.6 Southeast Asia
  26. 8.5.7 India
  27. 8.5.8 Australia
  28. 8.6 South America
  29. 8.6.1 South America Herpes Zoste Drug Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 8.6.2 South America Herpes Zoste Drug Consumption by Country (2021-2032)
  31. 8.6.3 Brazil
  32. 8.6.4 Argentina
  33. 8.6.5 Chile
  34. 8.6.6 Colombia
  35. 8.7 Middle East & Africa
  36. 8.7.1 Middle East & Africa Herpes Zoste Drug Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  37. 8.7.2 Middle East & Africa Herpes Zoste Drug Consumption by Country (2021-2032)
  38. 8.7.3 Egypt
  39. 8.7.4 South Africa
  40. 8.7.5 Israel
  41. 8.7.6 Türkiye
  42. 8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
  1. 9.1 Herpes Zoste Drug Value Chain Analysis
  2. 9.1.1 Herpes Zoste Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Herpes Zoste Drug Production Mode & Process
  6. 9.2 Herpes Zoste Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Herpes Zoste Drug Distributors
  9. 9.2.3 Herpes Zoste Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst